Jason M. Klein

Private Equity Matters:

• Represented a private equity fund in its acquisition of a distributor of corrugated products and packaging supplies in Florida.
• Represented a private equity fund in its sale of a company that provides credit related services to mortgage lenders to a private equity fund for $320 million.
• Represented a California private equity fund in the acquisition of substantially all of the assets of a company that provides continuing education services to dentists. 
• Represented a California private equity fund in the acquisition of a platform Colorado fire protection services company and numerous add-on acquisitions in the Southwest U.S.
• Represented a Cleveland, Ohio based private equity fund in its acquisition of a Florida sports supplement company.
• Represented a California private equity fund in the acquisition of substantially all of the assets of an upscale retail candy business with more than 60 locations in 27 states pursuant to a §363 sale out of bankruptcy.
• Represented a private equity fund in its purchase of assets of five companies, located in Washington, Pennsylvania, Connecticut and Massachusetts, that provide credit related services to mortgage lenders.

Middle Market Representative Matters:

• Represented a synthetic fiber manufacturer, located in Kansas, in its equity sale to a strategic buyer.
• Represented multiple fire protection services companies located in Massachusetts and Georgia in their sale of stock to a large strategic buyer.
• Represented a company in the purchase of a Colorado company that is engaged in the business of providing multi-lingual product and service taxonomies. 
• Represented a modular assembly, sequencing and supply chain company located in South Carolina in its sale of stock to a strategic buyer.
• Represented a California meat packing and distribution company in the sale of its assets to a public company.
• Represented a large manufacturer of agricultural baler twines and netwrap located in Minnesota in the sale of certain assets to a strategic multi-national company.  
• Represented an Ohio drug safety and metabolism, bioanalytical services and agrochemicals company in the sale of its units to a multi-national CRO and clinical trials management company.
• Represented a professional employer organization in the sale of its stock to a strategic national PEO company.
• Represented Ricerca Biosciences, LLC in the sale of its chemical development division to a multi-national pharmaceutical and biotech company.
• Represented a large manufacturer located in Tennessee in the sale of certain assets to a private equity backed company as part of an add-on acquisition.
• Represented a large manufacturer located in Oklahoma in the sale of certain assets to current management.
• Represented a large manufacturer located in Kansas in the sale of certain assets to a strategic multi-national company.
• Represented an Ohio company in its acquisition of substantially all of the assets of a retail wine shop and drive-thru business.
• Represented a multi-national inks and coatings manufacturer in the acquisition of substantially all of the assets of a large U.S. based inks and coatings manufacturer for $100 million.
• Represented a security installation company in its strategic acquisitions of assets of companies. 

Distressed M&A Matters:

• Represented a private equity fund in its purchase of e-commerce business assets of a menswear fashion brand via an assignment for the benefit of creditors.
• Represented the Assignee in its sale of virtual reality assets on Pier 39 in San Francisco via an assignment for the benefit of creditors.
• Represented Quaker Steak and Lube, owner, operator and franchisor of over 65 casual dining restaurants, in the sale of substantially all of its assets to a strategic public company buyer pursuant to a §363 sale out of bankruptcy.
• Represented a private equity fund in the acquisition of substantially all of the assets of an upscale retail candy business with more than 60 locations in 27 states pursuant to a §363 sale out of bankruptcy.
• Represented a company in its acquisition of substantially all of the assets of a deli restaurant chain in Florida with more than 20 locations pursuant to a §363 sale out of bankruptcy.

Healthcare Representative Matters:

• Represented a residential addiction treatment center, located in Georgia, in its sale of equity to a large national company.
• Represented a substance abuse recovery center in Maine in its sale of equity to a specialty healthcare organization.
• Represented an Optometrist in the sale of his two locations in Georgia to a national optometry clinic.
• Represented a large hospital system in Louisiana in the sale of its outreach business to a publicly-traded laboratory company for $80 million.
• Represented a recovery center in New Mexico in its sale of assets to a specialty healthcare organization.
• Represented a Michigan dermatology, pathology and clinical trials group in the sale of its business to a private equity backed buyer.
• Represented a large pathology practice located in Missouri in the sale of its long-term care division to a laboratory and radiology services company. 
• Represented multiple Florida dermatology practices in the sale of their businesses to a private equity backed buyer.
• Acted as co-counsel to a West Coast dermatology group and counsel to the individual doctors in a $90 million recapitalization of its business.
• Represented a Midwestern dermatology and clinical trials practice group in the $33 million sale of its business to a private equity backed buyer.
• Represented multiple California dermatology practices in the sale of their businesses to a private equity backed buyer.
• Represented an Ohio radiology company in the sale of its practice to a private equity backed buyer.
• Represented a Pennsylvania substance abuse and drug rehabilitation center in its sale of stock to a public healthcare company.
• Represented a hospital-based pathology practice in the acquisition of substantially all of the assets of another pathology practice.
• Represented a large pathology practice located in Missouri in the sale of substantially all of its assets to a publicly-traded laboratory company for $60 million.